Article
The transcription-independent mitochondrial cell death pathway is defective in non-transformed cells containing the Pro47Ser variant of p53.
Cancer biology & therapy - 1 Jan 2018
Budina-Kolomets Anna, Barnoud Thibaut, Murphy Maureen E
Abstract excerpt
Approximately half of all human cancers contain mutations in the TP53 tumor suppressor. In addition to mutations, there are single nucleotide polymorphisms (SNPs) in TP53 that can dampen p53 function, and can increase cancer risk and decrease the efficacy of cancer therapy. Approximately 6% of Africans and 1% of African-Americans express a p53 allele with a serine instead of proline at position 47 (Pro47Ser, or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
